(R)-()-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine
97%
- Product Code: 229935
CAS:
442905-33-1
| Molecular Weight: | 756.85 g./mol | Molecular Formula: | C₄₆H₅₀N₂O₄P₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD04974235 | |
| Melting Point: | 190-194°C | Boiling Point: | |
| Density: | Storage Condition: | Room temperature |
Product Description:
Widely used as a chiral ligand in asymmetric catalysis, this compound plays a key role in enantioselective transformations, particularly in transition metal-catalyzed reactions. It is especially effective in palladium- and rhodium-catalyzed asymmetric cross-couplings and hydrogenations, where it helps achieve high enantiomeric excess. Its sterically hindered, electron-rich phosphine groups enhance metal coordination and stabilize catalytic intermediates, improving reaction efficiency and selectivity. Commonly applied in the synthesis of pharmaceuticals and fine chemicals, it enables the construction of chiral centers with precision, making it valuable in academic research and industrial drug development.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | Ft90,393.13 |
+
-
|
| 0.500 | 10-20 days | Ft447,591.79 |
+
-
|
(R)-()-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine
Widely used as a chiral ligand in asymmetric catalysis, this compound plays a key role in enantioselective transformations, particularly in transition metal-catalyzed reactions. It is especially effective in palladium- and rhodium-catalyzed asymmetric cross-couplings and hydrogenations, where it helps achieve high enantiomeric excess. Its sterically hindered, electron-rich phosphine groups enhance metal coordination and stabilize catalytic intermediates, improving reaction efficiency and selectivity. Commonly applied in the synthesis of pharmaceuticals and fine chemicals, it enables the construction of chiral centers with precision, making it valuable in academic research and industrial drug development.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :